CelluPro, ltd.

CelluPro, founded in 2018, is a biotechnology company dedicated to delivering high-performance serum-free cell culture media solutions for the global biopharmaceutical industry. Backed by a strong R&D platform, fully integrated in-house manufacturing capabilities, and cGMP-compliant quality system, the company provides media solutions defined by quality, consistency, and reliability. Our product portfolio supports a wide range of cell culture processes and applications, including antibody therapeutics, vaccines, biosimilars, and cell & gene therapies. Located in the Rongchang Pharmaceutical Biopark, CelluPro serves as a strategic partner to RemeGen, supporting the commercial production of China’s first domestic ADC drug. CelluPro is also the first Chinese cell culture media supplier fully compliant with global standards, with the capability to independently support FDA Biologics License Application (BLA) and EMA submissions. CelluPro provides scalable manufacturing and reliable global supply solutions for biopharmaceutical companies across process development and commercial production. The company now supports over 75 pipelines worldwide across different development stages. With strong expertise and dedication in cell culture media development, CelluPro is committed to advancing the global biopharmaceutical industry and building long-term partnerships with customers worldwide.